title: Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?
authors.affiliation: MKA Breast Cancer Clinic, Tepe Prime, 06800, Cankaya, Ankara, Turkey. altundag66@yahoo.com.
authors.forename: Kadri
authors.identifier: 0000-0003-3357-0096
authors.initials: K
authors.lastname: Altundag
mesh_terms: D001943:Breast Neoplasms; D002908:Chronic Disease; D006801:Humans; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases